Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT04634643
- Status
- Recruiting
Conditions
- NAFLD
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Usual diet and physical activity — OTHERPatients will be followed up to assess the effect of the usual diet and physical activity on development of NAFLD
Study Details
The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
Key Dates
- Start date
- Jun 28, 2021
- Status verified
- Jan 2025
- Primary completion
- Jan 30, 2026
- Completion
- Jan 30, 2026
Study Design
- Enrollment
- 260 participants (estimated)
Primary Outcome Measure
Lactate synthesis [ Time Frame: 60 months ]
Central Contacts
- Ermena REFUGJATI2032157119
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | Nicola Santoro, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Haven, CT
By research site
Related Studies
- Reversal of Lipid-Induced Insulin ResistanceRecruiting · Yale University · New Haven, Connecticut
- Digoxin In NASH (CODIN)PHASE2 · Recruiting · Yale University · New Haven, Connecticut
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri
- SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver DiseasePHASE2 · Not Yet Recruiting · Justin Ryder · Chicago, Illinois